[go: up one dir, main page]

UA90477C2 - Способ лечения гепатита с (варианты) - Google Patents

Способ лечения гепатита с (варианты)

Info

Publication number
UA90477C2
UA90477C2 UAA200701232A UAA200701232A UA90477C2 UA 90477 C2 UA90477 C2 UA 90477C2 UA A200701232 A UAA200701232 A UA A200701232A UA A200701232 A UAA200701232 A UA A200701232A UA 90477 C2 UA90477 C2 UA 90477C2
Authority
UA
Ukraine
Prior art keywords
methods
variants
treating hepatitis
prevention
treatment
Prior art date
Application number
UAA200701232A
Other languages
English (en)
Ukrainian (uk)
Inventor
Петер Сеонгву Хванг
Джеймс Такасуги
Хонгью Рен
Ричард Джеральд Вайлд
Антони Турпофф
Александер Арефолов
Гари Митчелл Карп
Гуангминг Чен
Джефри Аллен Кемпбелл
Кристин Эспирите
Консетта Френд
Женгксиан Гу
Такаши Комацу
Original Assignee
ПиТиСи ТЕРАПЬЮТИКС, ИНК.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ПиТиСи ТЕРАПЬЮТИКС, ИНК. filed Critical ПиТиСи ТЕРАПЬЮТИКС, ИНК.
Publication of UA90477C2 publication Critical patent/UA90477C2/ru

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Согласно этому изобретению были идентифицированы соединения, которые ингибируют репликацию вируса, преимущественно репликацию вируса гепатита С (HCV), и предложены способы их использования.В одном аспекте изобретения предложены соединения, пригодные для лечения или профилактики вирусной инфекции.В другом аспекте изобретения предложены соединения, пригодные для лечения или профилактики инфекции вируса гепатита С.
UAA200701232A 2004-07-14 2005-07-14 Способ лечения гепатита с (варианты) UA90477C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58748704P 2004-07-14 2004-07-14

Publications (1)

Publication Number Publication Date
UA90477C2 true UA90477C2 (ru) 2010-05-11

Family

ID=38744740

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200701232A UA90477C2 (ru) 2004-07-14 2005-07-14 Способ лечения гепатита с (варианты)

Country Status (3)

Country Link
CN (1) CN101027051A (ru)
UA (1) UA90477C2 (ru)
ZA (1) ZA200701235B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009322387A1 (en) 2008-12-03 2011-06-30 Presidio Pharmaceuticals, Inc. Inhibitors of HCV NS5A
WO2011112191A1 (en) * 2010-03-11 2011-09-15 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis c
CN102816104B (zh) * 2012-08-30 2014-05-21 浙江大学 一种3-氰基吲哚类化合物的合成方法
CN106008488B (zh) * 2016-05-20 2018-10-30 广东东阳光药业有限公司 氰基吲哚类衍生物及其制备方法和用途
SG11202005696YA (en) * 2017-12-19 2020-07-29 Bristol Myers Squibb Co Substituted indole compounds useful as tlr inhibitors

Also Published As

Publication number Publication date
ZA200701235B (en) 2009-10-28
CN101027051A (zh) 2007-08-29

Similar Documents

Publication Publication Date Title
EA200700243A1 (ru) Способы лечения гепатита с
WO2007001406A3 (en) Aryl-containing macrocyclic compounds
JO2318B1 (en) Nucleoside derivatives used as DNA-based viral RNA inhibitors
ZA200805304B (en) Anti-viral compounds
WO2001077091A3 (en) Ns5b hcv polymerase inhibitors
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
TW200833662A (en) 4,5-ring annulated indole derivatives and methods of use thereof
GEP20084545B (en) Introducing tlr7 ligands and prodrugs thereof for the treatment of hepatitis c viral infection
WO2004007512A3 (en) Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
WO2004000858A3 (en) Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
WO2004003138A3 (en) Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
WO2007081517A3 (en) Anti-viral compounds
WO2004014312A3 (en) Small-mer compositions and methods of use
NO20063958L (no) HIV integrase inhibitorer
WO2007084413A3 (en) Methods for treating hepatitis c
TW200833684A (en) 5,6-ring annulated indole derivatives and methods of use thereof
WO2006033995A3 (en) Thiazolidin-4-ones having anti-hepatitis b activity
WO2004009020A3 (en) Pyrrolopyrimidine thionucleoside analogs as antivirals
EA200900969A1 (ru) Макроциклические ингибиторы протеазы гепатита с
MX2009009473A (es) Compuestos para el tratamiento de hepatitis c.
MY141003A (en) Materials and methods for treating viral infections with a cysteamine compound
WO2010055164A3 (en) Isoquinolone derivatives as inhibitors of plavivirus replication
WO2010047830A3 (en) Agents for hcv treatment
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
WO2009029384A3 (en) Compounds for the treatment of hepatitis c